The in vivo study of the medicinal composition property of doxorubicin as a part of colloidal nanoparticles with the address fragment

Sanzhakov M.A.1, Ignatov D.V.1, Kostryukova L.V.1, Druzhilovskaya O.S.1, Medvedeva N.V.1 , Prozorovskyi V.N.1, Ipatova O.M.1

1. Institute of Biomedical Chemistry, Moscow, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20166202150      UDK: 577.2; 577.1      PubMed Id: 27143371
Year: 2016  Volume: 62  Issue: 2  Pages: 150-153
The use of targeted transport systems for drug delivery is a promising approach to improve pharmacokinetics of drug substances, accumulation in the lesion. In this study we have obtained and characterized the pharmaceutical composition of doxorubicin in colloidal nanoparticles equipped with targeted conjugates based on folic acid and biotin with dodecylamine. The inclusion of the address fragments into colloidal nanopartical was carried out without surface and drug substance modification The accumulation of anthracycline antibiotic doxorubicin in tumor tissue was compared in Lewis lung carcinoma mouse models after intravenous administration of the composition of colloidal nanoparticles with targeted conjugates biotin-dodecylamine and folic acid-dodecylamine or free doxorubicin. It was shown that the doxorubicin accumulation in tumor tissue when administered in drug compositions with targeted fragments are 2 times higher for the folic acid-dodecylamine conjugate and 1.4 times higher for the biotin-dodecylamine conjugate
Download PDF:

Sanzhakov M.A., Ignatov D.V., Kostryukova L.V., Druzhilovskaya O.S., Medvedeva N.V., Prozorovskyi V.N., Ipatova O.M. (2016) Biomeditsinskaya khimiya, 62(2), 150-153.
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)

© Institute of Biomedical Chemistry, Moscow, Russia